Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
motivated researcher to lead a project aimed at dissecting the molecular determinants of previously undefined forms of CTL-induced cancer cell death and evaluating the physiological relevance of these novel
-
use the model species thale cress (Arabidopsis thaliana) as a resource to help identify the molecular mechanisms and genes underlying responses to altered temperatures and parasite (co-)infection. We
-
cell walls, which have been implied in responses to the two parasites. We will also use the model species thale cress (Arabidopsis thaliana) as a resource to help identify the molecular mechanisms and
-
. The project will quantify how prokaryotic and eukaryotic gene expression patterns influence one another. The candidate will model the relationship between species relative abundances and gene expression to
-
PhD/doctoral degree in neurodegeneration research, neuropathology, pathology, etc. extensive experience in tumor histology/biology, also in brain tumors extensive experience in working with mouse models
-
-scale genomic datasets to uncover ecological and evolutionary drivers of change in genomic diversity with emphasis on the fluctuating and heterogenous coastal zone. The project will involve molecular
-
25 Sep 2025 Job Information Organisation/Company NTNU Norwegian University of Science and Technology Department The Department of Clinical and Molecular Medicine (IKOM) Research Field Medical
-
English English PhD Position at Biomaterial Science PhD Position – Serotonin Signaling in 3D Tissue Models Apply for this job See advertisement About the position / About the job Biomaterial Science (BIOMAT
-
antibacterial biomaterials to improve patient outcomes. Structured around three core scientific pillars—regenerative medicine, biomaterial science, and translational research models—SHIELD supports research
-
around three core scientific pillars—regenerative medicine, biomaterial science, and translational research models—SHIELD supports research on therapeutic strategies, novel antimicrobial materials, and